Silexion Therapeutics reported total assets of $4.25M and total liabilities of $4.20M for the quarter ended Jun 2026, down 26.8% year over year. This balance sheet covers 13 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash & EquivalentsCash & Equiv. | 6.44M | 4.59M | 1.70M | 1.97M | 1.19M | 6.15M | 3.47M | 9.24M | 5.99M | 2.41M | 2.23M | ||
| Cash & Current Investments | 6.44M | 4.59M | 1.70M | 1.97M | 1.19M | 6.15M | 3.47M | 9.24M | 5.99M | 2.41M | 2.23M | ||
| Prepaid Assets | 0.34M | 0.53M | 0.94M | 0.97M | 1.48M | 1.68M | 1.74M | 0.57M | 1.53M | 1.37M | |||
| Current Assets | 4.98M | 2.31M | 3.05M | 2.25M | 7.72M | 5.24M | 11.05M | 6.64M | 4.07M | 3.74M | |||
| Non-Current Assets | |||||||||||||
| Property, Plant & Equipment (Net) | 0.05M | 0.04M | 0.04M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.02M | 0.02M | |||
| Other Non-Current Assets | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.08M | 0.08M | 0.08M | 0.08M | 0.08M | 0.09M | 0.09M | |
| Non-Current Assets | 0.28M | 0.21M | 0.04M | 0.61M | 0.59M | 0.56M | 0.56M | 0.58M | 0.54M | 0.51M | |||
| Assets | 5.26M | 3.58M | 2.31M | 3.09M | 2.86M | 8.31M | 5.80M | 11.61M | 7.21M | 4.60M | 4.25M | ||
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payables | 0.32M | 0.28M | 0.80M | 0.93M | 0.72M | 0.69M | 0.95M | 0.79M | 0.91M | 1.18M | |||
| Payables | 0.32M | 0.28M | 0.80M | 0.93M | 0.72M | 0.69M | 0.95M | 0.79M | 0.91M | 1.18M | |||
| Other Accumulated Expenses | 0.11M | 0.15M | 1.36M | 0.28M | 1.38M | 1.86M | 0.79M | 0.89M | 0.66M | 0.94M | 0.91M | 1.55M | |
| Total Current Liabilities | 2.20M | 2.36M | 3.58M | 3.52M | 2.40M | 2.15M | 2.79M | 2.76M | 4.06M | 3.98M | |||
| Non-Current Liabilities | |||||||||||||
| Non-Current Debt | 3.11M | 2.96M | 2.99M | 3.19M | 1.54M | 1.57M | |||||||
| Preferred Stock Liabilities | 15.06M | 15.06M | |||||||||||
| Minority Interest | 3.42M | 3.35M | |||||||||||
| Operating Leases | 0.06M | 0.01M | 0.37M | 0.33M | 0.34M | 0.31M | 0.29M | 0.25M | 0.23M | ||||
| Total Non-Current Liabilities | 0.06M | 0.01M | 4.08M | 3.33M | 3.33M | 3.53M | 1.85M | 1.85M | 0.25M | 0.23M | |||
| Total Liabilities | 20.73M | 1.98M | 2.16M | 7.67M | 6.85M | 5.72M | 5.68M | 4.64M | 4.61M | 4.31M | 4.20M | ||
| Shareholder's Equity | |||||||||||||
| Total Debt | 3.11M | 2.96M | 2.99M | 3.19M | 1.54M | 1.57M | |||||||
| Common Equity | 5.42M | -4.65M | -15.48M | 1.61M | 0.15M | -4.58M | -3.99M | 2.59M | 0.12M | 6.98M | 2.60M | 0.29M | 0.04M |
| Liabilities and Shareholders Equity | 5.26M | 3.58M | 2.31M | 3.09M | 2.86M | 8.31M | 5.80M | 11.61M | 7.21M | 4.60M | 4.25M | ||
| Retained Earnings | -26.81M | -29.66M | -41.58M | -43.25M | -44.99M | -47.49M | -50.75M | -55.17M | -57.90M | -61.45M | |||
| Preferred Shares | 7.31M | 7.31M |
Pull Silexion Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=SLXN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "SLXN", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=SLXN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();